Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group.
Gianni BisognoVeronique Minard ColinMyriam Ben ArushJulia DaragjatiBeatrice CoppadoroSoledad Gallego MelconRita AlaggioNaima SmeuldersPeter MudryAngelica ZinJohannes H M MerksOlga SlaterPublished in: Pediatric blood & cancer (2021)
Patients with congenital RMS presented with a favorable disease, allowing weight- and age-adjusted doses of chemotherapy and avoidance of irradiation, without compromising the outcome.